Purity Biologics is a biotechnology company commercializing OneAI™, a biospectral characterization platform designed to make complex biologics more objectively and repeatably measurable.
OneAI™ combines non-contact biospectral imaging with computational analysis to support high-value applications including biosimilar comparability, manufacturing consistency, advanced biologic characterization, and product and intellectual-property differentiation.
Purity Biologics works directly with biopharmaceutical companies, biologic product developers, and industry partners to apply OneAI to real-world analytical and commercial challenges.

Founder & CEO
Commercialization • Strategy • Partnerships

Lead Scientist
Biochemist • Biospectral Imaging • OneAI™ Development

Engineering & Systems Development
Imaging Systems • AI Integration • OneAI™ Development

Biological & Translational Strategy
Biologics Development • Translation • Strategic Partnerships • Regulatory

Commercial & Strategic Partnerships
Biopharma • Business Development • Industry Partnerships
Copyright © 2026 Purity Biologics Inc - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.